» Articles » PMID: 31354847

Intestinal Absorption Profile of Three Polygala Oligosaccharide Esters in Polygalae Radix and the Effects of Other Components in Polygalae Radix on Their Absorption

Overview
Date 2019 Jul 30
PMID 31354847
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Oligosaccharide esters, which are among the main active components of Polygalae Radix (PR), demonstrate significant pharmacological activities in the human nervous system. In our previous research, some other constituents in PR were able to improve the bioavailability of oligosaccharide esters such as sibiricose A5 (SA5), sibiricose A6 (SA6), and 3,6'-disinapoyl sucrose (DISS), but the related components and their underlying mechanisms remain unknown. The present study aimed to investigate the intestinal absorptive profile of SA5, SA6, and DISS and the absorptive behavior influenced by the coadministration of polygalaxanthone III and total saponins of PR (TS) using an everted rat gut sac model, along with the possible mechanisms that may influence absorption. The results showed that TS could significantly enhance the absorption of SA5, SA6, and DISS monomers. Verapamil, a P-glycoprotein inhibitor, was able to elevate the absorption of SA5 and SA6, and an absorption experiment using Rho123 led us to conclude that TS influenced the absorption of SA5 and SA6 in a manner similar to that of a P-glycoprotein inhibitor. Sodium caprate, a paracellular absorption enhancer, was found to increase the absorption of SA5, SA6, and DISS. Results showed that the absorption mechanisms of SA5 and SA6 may combine active transport with paracellular passive penetration, while DISS's absorption was dominated by paracellular passive penetration. However, the relationship between polygala saponins and the absorption of SA5, SA6, and DISS by paracellular passive penetration remain to be examined. This is the direction of our future research.

Citing Articles

Saponin components in as potential candidate drugs for treating dementia.

Li S, Hou Z, Ye T, Song X, Hu X, Chen J Front Pharmacol. 2024; 15:1431894.

PMID: 39050746 PMC: 11266144. DOI: 10.3389/fphar.2024.1431894.


Comprehensive evaluation of chemical constituents and antioxidant activity between crude and processed Polygalae radix based on UPLC-Q-TOF-MS/MS combined with multivariate statistical analysis.

Luo Y, Hu B, Ji H, Jing Y, Dang X, Zhang H Heliyon. 2024; 10(6):e27622.

PMID: 38515733 PMC: 10955230. DOI: 10.1016/j.heliyon.2024.e27622.


Isolation, Characterization and In Silico Studies of Secondary Metabolites from the Whole Plant of Peşmen & Erik.

Unlu A, Terali K, Ugurlu Aydin Z, Donmez A, Yusufoglu H, Calis I Molecules. 2022; 27(3).

PMID: 35163950 PMC: 8838668. DOI: 10.3390/molecules27030684.

References
1.
Sharma P, Chawla H, Panchagnula R . LC determination of cephalosporins in in vitro rat intestinal sac absorption model. J Pharm Biomed Anal. 2001; 27(1-2):39-50. DOI: 10.1016/s0731-7085(01)00506-4. View

2.
Kobayashi S, Miyase T, Noguchi H . Polyphenolic glycosides and oligosaccharide multiesters from the roots of Polygala dalmaisiana. J Nat Prod. 2002; 65(3):319-28. DOI: 10.1021/np010434n. View

3.
Ikeya Y, Takeda S, Tunakawa M, Karakida H, Toda K, Yamaguchi T . Cognitive improving and cerebral protective effects of acylated oligosaccharides in Polygala tenuifolia. Biol Pharm Bull. 2004; 27(7):1081-5. DOI: 10.1248/bpb.27.1081. View

4.
Jiang Y, Zhang N, Cui Z, Tu P . [Fingerprint of Polygala tenuifolia by high performance liquid chromatography]. Yao Xue Xue Bao. 2006; 41(2):179-83. View

5.
Naito R, Tohda C . Characterization of anti-neurodegenerative effects of Polygala tenuifolia in Abeta(25-35)-treated cortical neurons. Biol Pharm Bull. 2006; 29(9):1892-6. DOI: 10.1248/bpb.29.1892. View